Clinical Trial: Clinical Study of CVL006 Combination With 9MW2821

U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07615660) titled 'Clinical Study of CVL006 Combination With 9MW2821' on May 06.

Brief Summary: This study is a multi-center, open-label, dose-escalation and dose-optimized phase I/II clinical trial. Objective: To determine the safety, tolerability, PK characteristics and preliminary efficacy data of CVL006 combined with 9MW821 patients with advanced solid tumors.

Study Start Date: May 15

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumor

Intervention: DRUG: CVL006 in combination with 9MW2821

CVL006 in combination with 9MW2821

DRUG: CVL006 in combination with 9MW2821

CVL006 in combination with 9MW2821

Recruitment Status: NOT_YET_RECRU...